Rank #97
Dilip Shanghvi
Net worth $26.0B
Pharmaceuticals · India
- Born
- Oct 01, 1955
- Age
- 70
- Source
- Pharmaceuticals
- Residence
- Mumbai
- Citizenship
- India
- Marital status
- Married
- Children
- 2
- Education
- Bachelor of Arts/Science, Calcutta University
Net worth over time
Biography
- The son of a pharmaceuticals distributor, Dilip Shanghvi borrowed $200 from his father to start Sun Pharmaceutical Industries in 1983 to make psychiatric drugs.
- The company is India's most valuable listed pharma outfit and gets two-thirds of its $6.1 billion annual revenue from overseas markets.
- He grew Sun through a series of acquisitions, the biggest of which was the 2014 purchase of scandal-tainted rival Ranbaxy Laboratories for $4 billion.
- Sun Pharma acquired U.S. skin cancer drug maker Checkpoint Therapeutics in May 2025 for $355 million.
- In February 2025, his son Aalok was appointed as chief operating officer of Sun Pharma.
- Photos of Shanghvi's family deity, Shrinathji, adorn Sun's factories and offices.
- Shanghvi 's favorite cuisine is south Indian.
- In 2023, Sun Pharma completed the $576 million acquisition of U.S.-based Concert Pharmaceuticals.
Financial assets
| Exchange | Ticker | Shares | Price |
|---|